Predictive Value of Ipratropium Responsiveness on Posterior Nasal Nerve Neurectomy Outcomes in Chronic Rhinitis
Otolaryngology–Head and Neck Surgery · 2026
DOI: 10.1002/ohn.70099 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2026. Written by Sainiteesh Maddineni and 5 co-authors. Institution: Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Palo Alto, 94304, California, USA. Major MEDLINE topics: Rhinitis, Ipratropium, Denervation, Nose. 23 references.
Abstract (original language)
Objective
Procedures targeting the posterior nasal nerve (PNN) are effective in treating chronic rhinitis after failed medical therapy. We evaluate how ipratropium response predicts PNN intervention outcomes. Study Design Retrospective review from January 2013 to June 2025. Study Setting Tertiary academic center.
Methods
We reviewed patients with chronic rhinitis who trialed ipratropium nasal spray and received PNN surgical neurectomy or in‐office ablation (cryotherapy or radiofrequency ablation). Ipratropium responsiveness was self‐reported. Outcomes were assessed with the SNOT‐22 questionnaire, focusing on rhinologic components.
Results
81 patients (43 male, 38 female; mean age 57.9 years) were included, of whom 44 (54.3%) reported response to ipratropium. SNOT‐22 rhinologic subdomain scores improved significantly following both in‐office PNN ablation (17.7 ± 5.8‐14.5 ± 7.1, P = .04) and surgical neurectomy (19.1 ± 6.7‐15.8 ± 7.3, P = .02). After PNN surgical neurectomy, ipratropium responders demonstrated significant improvement in postnasal drip ( P = .03), nonresponders in rhinorrhea ( P = .04), and both had similar rates of clinically meaningful improvement (MCID) in the SNOT‐22 rhinologic subdomain (45.2% vs 50.0%, P = .73). In contrast, for in‐office PNN ablation, ipratropium responders had a significantly higher rate of MCID achievement (64.7% vs 27.8%, P = .03) and significant improvements in rhinorrhea ( P = .03), thick nasal discharge ( P = .03), and rhinologic subdomain scores ( P = .03), while nonresponders had no significant symptom changes following in‐office ablation.
Conclusion
Patients with positive response to ipratropium may be more likely to benefit from PNN in‐office ablation techniques. Ipratropium response is not predictive of outcome for surgical PNN neurectomy, as both responders and nonresponders may experience benefit.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Palo Alto, 94304, California, USA.
ORCID profiles: Sainiteesh Maddineni, Michael T Chang
Cite
APA
Maddineni, S., Hwang, P. H., Ayoub, N. F., Patel, Z. M., Nayak, J. V., & Chang, M. T. (2026). Predictive Value of Ipratropium Responsiveness on Posterior Nasal Nerve Neurectomy Outcomes in Chronic Rhinitis. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70099
Vancouver
Maddineni S, Hwang PH, Ayoub NF, Patel ZM, Nayak JV, Chang MT. Predictive Value of Ipratropium Responsiveness on Posterior Nasal Nerve Neurectomy Outcomes in Chronic Rhinitis. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70099
BibTeX
@article{Maddineni2026,
author = {Maddineni, Sainiteesh and Hwang, Peter H and Ayoub, Noel F and Patel, Zara M and Nayak, Jayakar V and Chang, Michael T},
title = {Predictive Value of Ipratropium Responsiveness on Posterior Nasal Nerve Neurectomy Outcomes in Chronic Rhinitis},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70099}
}
EUVIMED